Domain

Details

pharmon.biz appears in our database 1584 times

  • Details

  • Abuse History

  • Whois

Date IP Address Username Email Location Evidence
10-Jul-20 00:58
193.202.82.103
nuyvefwgy
 
eilpklpzk@pharmon.biz
   
10-Jul-20 00:58
193.202.82.103
nuyvefwgy
 
eilpklpzk@pharmon.biz
   
6-Jul-20 15:51
193.93.192.166
jvadeksqd
 
kqnrhxjsa@pharmon.biz
United Kingdom  
6-Jul-20 15:38
185.14.194.64
oncrvcdtu
 
bsezptrog@pharmon.biz
United Kingdom  
4-Jul-20 16:21
185.89.100.114
qzrmhkhzg
 
wiscetuge@pharmon.biz
Germany  
23-Jun-20 14:29
213.108.3.109
OttoWasing
 
dnmvlaiffaxe@pharmon.biz
Russian Federation  
22-Jun-20 23:34
213.108.0.224
Pilar29W95
 
vwgwyfuvtlwn@pharmon.biz
Russian Federation  
22-Jun-20 23:34
213.108.0.224
Pilar29W95
 
vwgwyfuvtlwn@pharmon.biz
Russian Federation  
22-Jun-20 21:54
213.108.0.143
StefanieLov
 
pvkmczxrwkkg@pharmon.biz
Russian Federation  
22-Jun-20 19:55
45.10.167.173
ChastityKin
 
hkxenivxdkos@pharmon.biz
   
22-Jun-20 18:59
213.108.3.77
JodieDozie
 
scdgonphzlgb@pharmon.biz
Russian Federation Evidence
22-Jun-20 17:07
213.108.3.110
ChangHutch
 
bbwnyndrngqz@pharmon.biz
Russian Federation  
22-Jun-20 15:56
194.104.8.148
BrandieDol
 
cbshxrihlrqg@pharmon.biz
Netherlands  
22-Jun-20 13:18
77.220.195.115
MaricruzO5
 
gcohxdxkifmk@pharmon.biz
Uzbekistan  
22-Jun-20 12:35
45.10.167.237
SolomonBoo
 
jcrfpmfhjnpp@pharmon.biz
   
22-Jun-20 12:35
45.10.167.237
SolomonBoo
 
jcrfpmfhjnpp@pharmon.biz
   
22-Jun-20 12:35
45.10.167.237
SolomonBoo
 
jcrfpmfhjnpp@pharmon.biz
   
22-Jun-20 12:03
213.108.0.178
PI
 
ghzlbgegjavn@pharmon.biz
Russian Federation  
22-Jun-20 10:19
77.220.192.253
HeribertoC
 
riilmisetqvx@pharmon.biz
Uzbekistan  
22-Jun-20 08:32
77.220.195.204
LinwoodKile
 
iemyibbdmmdh@pharmon.biz
Uzbekistan  
22-Jun-20 06:41
141.98.84.31
NelsonShake
 
bhgkorcfrftn@pharmon.biz
   
22-Jun-20 06:21
5.183.252.243
AidenSch
 
gkiqouwxuqzf@pharmon.biz
   
22-Jun-20 03:34
213.108.3.41
IM
 
ksytvwncvahx@pharmon.biz
Russian Federation Evidence
22-Jun-20 02:22
5.183.252.112
Charli87S9
 
vubnapbftohl@pharmon.biz
   
22-Jun-20 01:07
213.108.0.199
DH
 
viytefowozbo@pharmon.biz
Russian Federation Evidence
21-Jun-20 23:15
5.183.252.138
AudreyThre
 
pmdgvlnfzqmz@pharmon.biz
   
21-Jun-20 20:39
5.183.252.164
CarissaU55
 
rjwwboumxjbn@pharmon.biz
   
21-Jun-20 20:12
213.108.0.199
GI
 
wbercnmhyhqr@pharmon.biz
Russian Federation  
21-Jun-20 17:31
77.220.192.170
QuentinMau
 
ollbflcwivtl@pharmon.biz
Uzbekistan  
21-Jun-20 14:11
141.98.84.14
JamelSchlei
 
wzjcpqrvljcm@pharmon.biz
   
21-Jun-20 12:04
194.104.8.120
UlyssesMcLe
 
vzwoeaxqfjzx@pharmon.biz
Netherlands  
21-Jun-20 11:35
45.10.164.130
FB
 
ylawbkqrmmkg@pharmon.biz
   
21-Jun-20 09:15
213.108.3.222
FN
 
kczohciliawd@pharmon.biz
Russian Federation  
21-Jun-20 00:25
213.108.3.223
KennyKump08
 
uumdltxqahzv@pharmon.biz
Russian Federation  
20-Jun-20 22:54
213.108.3.145
SalinaGolds
 
vktvjhhfndtf@pharmon.biz
Russian Federation  
18-Jun-20 05:21
5.183.252.122
CortneySto
 
bjsucwplerms@pharmon.biz
   
17-Jun-20 18:56
45.10.164.155
TajHargrov
 
byifrhzeycgq@pharmon.biz
   
17-Jun-20 18:56
77.220.192.68
Doretha07J
 
iazmlhrpefov@pharmon.biz
Uzbekistan  
17-Jun-20 18:29
45.10.167.180
AlexanderH
 
hrugiscjjlaq@pharmon.biz
   
17-Jun-20 16:13
77.220.195.163
GlennQch48
 
dglyujairuai@pharmon.biz
Uzbekistan  
17-Jun-20 13:24
5.183.252.126
StephanyAs
 
dyhohdpqjwmf@pharmon.biz
   
16-Jun-20 18:47
194.104.8.165
MayaRuzick
 
mourxfnetmko@pharmon.biz
Netherlands  
16-Jun-20 18:47
77.220.192.242
AustinCono
 
hlraqykujpzz@pharmon.biz
Uzbekistan  
16-Jun-20 05:33
194.104.8.227
DenisBaugha
 
xizuuchbhoec@pharmon.biz
Netherlands  
15-Jun-20 16:18
194.104.8.227
DenisBaugha
 
xizuuchbhoec@pharmon.biz
Netherlands  
15-Jun-20 12:58
45.10.164.236
Tracie
 
eoblogmhkamq@pharmon.biz
   
14-Jun-20 08:20
213.108.0.23
AimeeBohn61
 
ptgidzknjexw@pharmon.biz
Russian Federation  
13-Jun-20 22:17
213.108.0.187
KatherinaDa
 
yunnjchkddby@pharmon.biz
Russian Federation  
13-Jun-20 19:32
141.98.84.108
SheliaLongm
 
wzasamujcblw@pharmon.biz
   
12-Jun-20 06:06
95.85.68.14
cgoghjmku
 
efcnpsnxa@pharmon.biz
Russian Federation  
10-Jun-20 13:00
213.108.3.162
frcmuahq
 
ljbscncmu@pharmon.biz
Russian Federation Evidence
10-Jun-20 11:27
77.220.192.64
awhpxtja
 
yfmyfjxcn@pharmon.biz
Uzbekistan  
10-Jun-20 11:27
77.220.192.64
awhpxtja
 
yfmyfjxcn@pharmon.biz
Uzbekistan  
10-Jun-20 04:22
5.183.252.195
anuqpdnc
 
lksfoxnpt@pharmon.biz
   
10-Jun-20 04:22
5.183.252.195
anuqpdnc
 
lksfoxnpt@pharmon.biz
   
9-Jun-20 18:43
77.220.195.216
fmczfihk
 
agbdlalws@pharmon.biz
Uzbekistan Evidence
9-Jun-20 13:59
213.108.0.91
cifnemew
 
dlmlrolxy@pharmon.biz
Russian Federation  
9-Jun-20 07:54
213.108.3.14
dwuwfivs
 
eghojwjyu@pharmon.biz
Russian Federation  
9-Jun-20 06:34
5.183.252.181
xivuxztv
 
bkcqwgtnr@pharmon.biz
   
8-Jun-20 16:20
45.10.164.20
wqctlovc
 
dnnvgfjjj@pharmon.biz
  Evidence
8-Jun-20 13:00
213.108.0.238
jywqeynp
 
vdttmjhuz@pharmon.biz
Russian Federation  
8-Jun-20 12:41
213.108.0.202
bqoghgpb
 
axqxlgelu@pharmon.biz
Russian Federation  
8-Jun-20 10:45
45.10.167.102
ldxdvutw
 
fkiampidr@pharmon.biz
  Evidence
8-Jun-20 10:40
45.10.164.236
qlteonqp
 
mvhqohpar@pharmon.biz
  Evidence
8-Jun-20 08:50
45.10.167.81
jngqlynf
 
socvdmska@pharmon.biz
  Evidence
8-Jun-20 04:40
213.108.0.143
gujncaey
 
uubtsegai@pharmon.biz
Russian Federation Evidence
8-Jun-20 03:15
45.10.164.156
nwurdjqf
 
gemphtdje@pharmon.biz
  Evidence
8-Jun-20 02:45
45.10.164.226
xgklbcqf
 
rxatdvyqt@pharmon.biz
  Evidence
8-Jun-20 00:55
5.183.252.33
xufcjvtw
 
lncvqsomq@pharmon.biz
  Evidence
6-Jun-20 18:48
45.10.167.68
oxgpwkoe
 
swvbwaoil@pharmon.biz
   
6-Jun-20 18:48
77.220.195.140
oxgpwkoe
 
swvbwaoil@pharmon.biz
Uzbekistan  
6-Jun-20 16:51
141.98.84.171
jaxadwzp
 
xsjcquvnw@pharmon.biz
   
6-Jun-20 12:29
95.85.71.118
lhtogivob
 
zhlytrgea@pharmon.biz
Russian Federation  
5-Jun-20 23:58
95.181.177.210
sldxxbxbf
 
rhezahuax@pharmon.biz
Poland  
5-Jun-20 22:24
95.181.176.128
kgvdtnscy
 
aqvvsomvl@pharmon.biz
Latvia  
5-Jun-20 09:50
188.68.0.11
rwpzfprtb
 
klsxghqnr@pharmon.biz
United Kingdom Evidence
5-Jun-20 09:25
193.203.11.218
mzomjzidl
 
qscurtowm@pharmon.biz
  Evidence
5-Jun-20 09:20
91.222.239.103
qunzlarqt
 
anjnfakra@pharmon.biz
Russian Federation Evidence
5-Jun-20 08:33
188.68.3.179
tglwmjymz
 
ajkvsoxmb@pharmon.biz
Czech Republic  
5-Jun-20 08:10
194.104.10.202
rtewduydw
 
vsbzocfyy@pharmon.biz
Netherlands Evidence
5-Jun-20 07:00
83.142.52.34
obglcviyd
 
moodynojr@pharmon.biz
  Evidence
5-Jun-20 03:17
45.80.104.200
yjplrpgox
 
uacehvsfb@pharmon.biz
   
5-Jun-20 02:20
46.161.61.134
tbjzttvsi
 
tvnuifvdw@pharmon.biz
Belgium Evidence
5-Jun-20 00:03
95.181.218.168
fekcmgczv
 
lfovlfoje@pharmon.biz
Russian Federation  
5-Jun-20 00:03
95.181.218.168
fekcmgczv
 
lfovlfoje@pharmon.biz
Russian Federation  
4-Jun-20 23:46
81.22.47.99
tocjjjcgz
 
rcjswmnkv@pharmon.biz
United Kingdom  
4-Jun-20 23:46
81.22.47.99
tocjjjcgz
 
rcjswmnkv@pharmon.biz
United Kingdom  
4-Jun-20 23:28
185.89.100.41
zdpomhrar
 
srpvphpjx@pharmon.biz
Germany  
4-Jun-20 23:27
188.68.3.148
zdpomhrar
 
srpvphpjx@pharmon.biz
Czech Republic  
4-Jun-20 22:53
83.142.53.207
gugwpbmdh
 
cxxhqusee@pharmon.biz
   
4-Jun-20 22:53
83.142.53.207
gugwpbmdh
 
cxxhqusee@pharmon.biz
   
4-Jun-20 22:53
83.142.53.207
gugwpbmdh
 
cxxhqusee@pharmon.biz
   
4-Jun-20 22:53
83.142.53.207
gugwpbmdh
 
cxxhqusee@pharmon.biz
   
4-Jun-20 21:36
85.202.194.68
jauqimglw
 
tveknwpuw@pharmon.biz
   
4-Jun-20 21:36
85.202.194.68
jauqimglw
 
tveknwpuw@pharmon.biz
   
4-Jun-20 21:36
85.202.194.68
jauqimglw
 
tveknwpuw@pharmon.biz
   
4-Jun-20 21:36
85.202.194.68
jauqimglw
 
tveknwpuw@pharmon.biz
   
4-Jun-20 20:57
91.222.236.123
jbdytakfg
 
ycczvzyri@pharmon.biz
Russian Federation  
4-Jun-20 20:30
188.68.3.149
iloxwdsst
 
xlwppumxo@pharmon.biz
Czech Republic Evidence
4-Jun-20 19:25
91.222.236.123
mgvoisyop
 
wbzdrwaws@pharmon.biz
Russian Federation Evidence
4-Jun-20 17:30
212.115.51.177
snvxlsttm
 
uiraxvrjq@pharmon.biz
  Evidence
4-Jun-20 16:50
188.68.3.189
nqqddmjsa
 
eyzspdqen@pharmon.biz
Czech Republic Evidence
4-Jun-20 16:40
185.250.46.242
tbbreetzd
 
yyjspvsyr@pharmon.biz
  Evidence
4-Jun-20 15:52
193.202.83.209
jcralfgye
 
giapatuqf@pharmon.biz
   
4-Jun-20 15:48
45.140.207.93
irmenwdkv
 
eznopkzaj@pharmon.biz
   
4-Jun-20 15:48
91.222.236.114
irmenwdkv
 
eznopkzaj@pharmon.biz
Russian Federation  
4-Jun-20 12:54
193.203.11.64
ezbchuzti
 
exusggyso@pharmon.biz
   
4-Jun-20 12:19
176.119.141.204
ulgugpbrd
 
oyrwnspwz@pharmon.biz
   
4-Jun-20 12:16
212.60.21.107
cgybkwvor
 
vyetuwvdg@pharmon.biz
  Evidence
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 09:03
83.142.52.68
tjrwvbvtf
 
polpxtzln@pharmon.biz
   
4-Jun-20 07:30
37.44.252.168
jksewfbui
 
fhmdxnmpc@pharmon.biz
Russian Federation Evidence
3-Jun-20 19:30
2.57.77.101
hkunervtn
 
ifehzqrzg@pharmon.biz
  Evidence
3-Jun-20 15:31
46.161.61.69
jzqrllily
 
mxxcfbckx@pharmon.biz
Iceland  
3-Jun-20 14:00
95.85.80.69
uunsajoat
 
lurrqunax@pharmon.biz
United Kingdom Evidence
3-Jun-20 10:57
81.22.47.47
mfpsdrvls
 
atbdjdaza@pharmon.biz
United Kingdom  
3-Jun-20 10:57
81.22.47.47
mfpsdrvls
 
atbdjdaza@pharmon.biz
United Kingdom  
3-Jun-20 10:57
81.22.47.47
mfpsdrvls
 
atbdjdaza@pharmon.biz
United Kingdom  
3-Jun-20 09:16
95.181.177.16
59830
 
uogkmhqwn@pharmon.biz
Poland  
3-Jun-20 09:16
95.181.177.16
59830
 
uogkmhqwn@pharmon.biz
Poland  
3-Jun-20 09:16
95.181.177.16
59830
 
uogkmhqwn@pharmon.biz
Poland  
3-Jun-20 09:16
95.181.177.16
59830
 
uogkmhqwn@pharmon.biz
Poland  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 09:09
104.156.91.29
ykytlckwh
 
zwcmngxko@pharmon.biz
United States  
3-Jun-20 08:34
91.222.236.138
jnysbrqvq
 
ixsqaupmm@pharmon.biz
Russian Federation  
3-Jun-20 07:47
185.250.44.67
zdchurpya
 
ldqlliqkg@pharmon.biz
   
3-Jun-20 07:20
185.89.100.56
dermlnbke
 
wpbhumpsw@pharmon.biz
Germany  
3-Jun-20 07:20
185.89.100.56
dermlnbke
 
wpbhumpsw@pharmon.biz
Germany  
3-Jun-20 05:00
94.158.22.223
pivfvnyct
 
wernoxeoc@pharmon.biz
  Evidence
3-Jun-20 04:16
185.46.84.225
nmhgjbkki
 
wbssaawye@pharmon.biz
Poland  
3-Jun-20 04:16
212.119.46.81
nmhgjbkki
 
wbssaawye@pharmon.biz
   
3-Jun-20 03:09
95.181.177.163
mboervyfj
 
kffbwjoel@pharmon.biz
Poland  
3-Jun-20 03:09
185.46.84.225
mboervyfj
 
kffbwjoel@pharmon.biz
Poland  
3-Jun-20 03:00
85.202.195.147
uprugjycb
 
dzttffhil@pharmon.biz
  Evidence
3-Jun-20 02:06
81.22.47.22
fmhonbytm
 
qccljxmyq@pharmon.biz
United Kingdom  
3-Jun-20 02:06
83.171.252.178
fmhonbytm
 
qccljxmyq@pharmon.biz
   
3-Jun-20 01:45
83.142.54.98
klveyphye
 
rgnzgnkqc@pharmon.biz
   
3-Jun-20 00:11
83.142.52.43
kstafzyzw
 
lxsbpnuyb@pharmon.biz
   
2-Jun-20 19:19
185.46.84.207
cwokqgvie
 
yccoiowms@pharmon.biz
Poland  
2-Jun-20 19:19
185.46.84.207
cwokqgvie
 
yccoiowms@pharmon.biz
Poland  
2-Jun-20 18:42
193.202.80.14
msdtabkjh
 
nrhupickp@pharmon.biz
   
2-Jun-20 18:40
77.220.194.19
bmhkchwwi
 
dmomgkhmn@pharmon.biz
Uzbekistan  
2-Jun-20 18:40
77.220.194.19
bmhkchwwi
 
dmomgkhmn@pharmon.biz
Uzbekistan  
2-Jun-20 18:40
77.220.194.19
bmhkchwwi
 
dmomgkhmn@pharmon.biz
Uzbekistan  
2-Jun-20 18:03
193.202.83.180
xcjryyjjq
 
kirrbvmwk@pharmon.biz
   
2-Jun-20 10:21
185.46.84.235
uorpvjbcy
 
mafgwhgnk@pharmon.biz
Poland  
2-Jun-20 05:15
81.22.47.64
bhmjxdmkz
 
ueyyglndr@pharmon.biz
United Kingdom Evidence
2-Jun-20 02:00
83.142.52.13
Dgvww
 
ahqyfzuvc@pharmon.biz
   
2-Jun-20 01:10
185.89.100.218
qjbslycve
 
ngdaujhfo@pharmon.biz
European Union  
2-Jun-20 01:10
185.89.100.218
qjbslycve
 
ngdaujhfo@pharmon.biz
European Union  
2-Jun-20 01:10
185.89.100.218
qjbslycve
 
ngdaujhfo@pharmon.biz
European Union  
2-Jun-20 01:10
185.89.100.218
qjbslycve
 
ngdaujhfo@pharmon.biz
European Union  
1-Jun-20 15:22
91.222.239.127
btzfwolyy
 
ylhwaczhl@pharmon.biz
Russian Federation Evidence
1-Jun-20 14:13
91.222.239.119
zqsjknlmx
 
fzspjbcek@pharmon.biz
Russian Federation  
1-Jun-20 14:13
81.22.47.20
zqsjknlmx
 
fzspjbcek@pharmon.biz
United Kingdom  
1-Jun-20 14:13
193.202.82.236
zqsjknlmx
 
fzspjbcek@pharmon.biz
   
1-Jun-20 03:41
193.202.82.181
zaszbtoxv
 
hvhiwysyu@pharmon.biz
   
1-Jun-20 03:10
188.68.3.170
ydnllzixc
 
okxbukubw@pharmon.biz
Czech Republic Evidence
31-May-20 23:55
185.88.100.191
kmcvfieaq
 
hdayxhsct@pharmon.biz
Russian Federation  
31-May-20 19:31
212.115.51.75
scghkwmbp
 
fupvkhgzp@pharmon.biz
   
31-May-20 17:22
185.14.194.56
bgskeoscu
 
mxadyzupt@pharmon.biz
United Kingdom  
31-May-20 17:19
91.222.239.111
fyiwpupnl
 
uaclnxbcx@pharmon.biz
Russian Federation  
31-May-20 16:57
83.142.53.101
zsbwqvjpg
 
dbwwpgdii@pharmon.biz
   
31-May-20 15:55
194.156.125.223
znglrbsnh
 
qunvlnajr@pharmon.biz
   
31-May-20 04:08
188.68.3.46
jqkzubbog
 
knqkcnqvb@pharmon.biz
Czech Republic  
31-May-20 04:08
188.68.3.46
jqkzubbog
 
knqkcnqvb@pharmon.biz
Czech Republic  
30-May-20 22:49
185.89.100.176
Тфчмина
 
prosqlidu@pharmon.biz
European Union  
30-May-20 22:43
176.119.141.90
faoxmllqf
 
gxoeiwxck@pharmon.biz
   
30-May-20 15:30
81.22.47.37
ntuqfuqkl
 
cnalwdpga@pharmon.biz
United Kingdom  
30-May-20 13:58
45.148.232.165
yemwuuqvf
 
csjsrwppw@pharmon.biz
   
30-May-20 13:45
46.161.60.47
egiprbxqh
 
qdtdjdemz@pharmon.biz
Spain  
30-May-20 13:05
185.89.100.237
yhmllheoz
 
vanvgzjvd@pharmon.biz
European Union Evidence
30-May-20 12:15
213.108.2.122
yfrzkndwr
 
ypjcyjqar@pharmon.biz
Russian Federation Evidence
30-May-20 09:18
185.89.100.242
zbqeplglj
 
khihtcfzo@pharmon.biz
European Union  
30-May-20 09:18
185.89.100.135
zbqeplglj
 
khihtcfzo@pharmon.biz
European Union  
30-May-20 02:55
45.138.100.80
oplynlcob
 
qnizkxmut@pharmon.biz
  Evidence
30-May-20 02:30
185.89.100.222
jeslxvjyu
 
eemjawuoq@pharmon.biz
European Union Evidence
30-May-20 02:30
45.148.232.128
jeslxvjyu
 
irmpuffhf@pharmon.biz
  Evidence
30-May-20 00:10
185.250.44.108
quqlyuqky
 
pcgemgiym@pharmon.biz
  Evidence
29-May-20 16:45
46.161.61.147
uqfrzsbnh
 
aydcpajpp@pharmon.biz
Belgium Evidence
29-May-20 15:56
193.203.8.17
ngmydqdqy
 
lkhfnqgqi@pharmon.biz
   
29-May-20 11:12
91.222.239.127
rzifcigyr
 
ejiqiyfqj@pharmon.biz
Russian Federation Evidence
29-May-20 10:00
83.142.54.127
vcvbxsrfm
 
geogyxdnq@pharmon.biz
   
29-May-20 10:00
83.142.54.127
vcvbxsrfm
 
geogyxdnq@pharmon.biz
   
29-May-20 10:00
83.142.54.127
vcvbxsrfm
 
geogyxdnq@pharmon.biz
   
29-May-20 09:55
91.222.239.119
csaxyiypa
 
ealukppdh@pharmon.biz
Russian Federation Evidence
29-May-20 09:55
95.85.69.242
csaxyiypa
 
ojcdhycns@pharmon.biz
Russian Federation Evidence
29-May-20 06:11
45.148.235.91
deyasvgrl
 
zppbjjpme@pharmon.biz
   
29-May-20 05:40
185.233.187.164
xyteohlwz
 
uczhlbmct@pharmon.biz
  Evidence
29-May-20 05:10
5.188.216.140
opwjxrrbh
 
kjcpooeuo@pharmon.biz
Netherlands Evidence
29-May-20 03:16
45.148.235.84
vyhybbtbd
 
whcrwtzuv@pharmon.biz
   
29-May-20 03:16
91.222.239.180
vyhybbtbd
 
whcrwtzuv@pharmon.biz
Russian Federation  
29-May-20 00:55
188.68.3.237
jubeetrji
 
obdinbgmy@pharmon.biz
Czech Republic Evidence
28-May-20 23:00
185.46.84.144
bytraxpul
 
dskmqrcqx@pharmon.biz
Poland Evidence
28-May-20 20:55
45.80.105.220
ipzvbcmbw
 
lnxacyusu@pharmon.biz
   
28-May-20 20:00
81.22.47.47
jsxahfehp
 
bbvenoldo@pharmon.biz
United Kingdom Evidence
28-May-20 19:04
45.148.235.140
rkttsmmta
 
nexacepla@pharmon.biz
   
28-May-20 17:21
188.68.0.75
mqgjqvvob
 
toehdfugs@pharmon.biz
United Kingdom  
28-May-20 16:51
185.46.84.207
tkkihuqco
 
ycniiygcf@pharmon.biz
Poland  
28-May-20 16:05
81.22.47.22
evsdoeurh
 
acdsputch@pharmon.biz
United Kingdom Evidence
28-May-20 15:00
81.22.47.37
kjhydteys
 
glwfaovsp@pharmon.biz
United Kingdom Evidence
28-May-20 11:15
45.148.234.31
uewtuvgli
 
gcntbzxtl@pharmon.biz
   
28-May-20 10:49
193.202.82.145
tzfasmvbs
 
ltgontoxw@pharmon.biz
   
28-May-20 10:49
45.140.206.40
tzfasmvbs
 
ltgontoxw@pharmon.biz
   
28-May-20 08:30
45.148.233.194
lhgofgfnb
 
uamzyntwc@pharmon.biz
  Evidence
28-May-20 08:10
91.204.14.159
lgutaupgn
 
ieyuwpbsm@pharmon.biz
Germany  
28-May-20 07:07
193.202.82.32
tommointf
 
ezmuyfjap@pharmon.biz
   
28-May-20 06:55
185.88.100.184
noozizbqe
 
urvjzzfjg@pharmon.biz
Russian Federation Evidence
28-May-20 06:34
185.233.187.40
osolrhfel
 
ejpjnydsz@pharmon.biz
   
28-May-20 06:24
95.181.176.128
rpnqgmkgi
 
ccaoytpfg@pharmon.biz
Latvia  
28-May-20 05:44
185.250.45.86
kutmtmtyq
 
dpifcbjrk@pharmon.biz
  Evidence
28-May-20 03:24
45.66.208.171
ajrowzhgo
 
tuumyzgzy@pharmon.biz
   
28-May-20 03:20
45.148.234.126
ebngtgzoy
 
elgyneyiv@pharmon.biz
   
28-May-20 01:45
45.148.234.126
deggsbgqh
 
dphydmuen@pharmon.biz
  Evidence
28-May-20 00:50
45.148.234.38
ozxrhzrzg
 
nwqbfucwn@pharmon.biz
  Evidence
27-May-20 21:13
45.148.234.74
dywvmacsk
 
naobggkfp@pharmon.biz
   
27-May-20 18:30
83.142.52.154
azoqtibpd
 
hxpvnngnd@pharmon.biz
  Evidence
27-May-20 16:45
45.80.104.162
vtynbvyaf
 
thkydpjjm@pharmon.biz
  Evidence
27-May-20 14:20
84.54.58.147
aggkdkzkv
 
fbnyjybvp@pharmon.biz
  Evidence
23-May-20 17:32
45.10.164.176
hohifsmx
 
ebyguxnkk@pharmon.biz
   
22-May-20 18:39
213.108.3.62
rcnqzqsq
 
nvygpfkdn@pharmon.biz
Russian Federation  
21-May-20 21:57
77.220.195.39
vxpmirty
 
dkvuqxnmo@pharmon.biz
Uzbekistan  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
185.46.85.156
pxofqjwm
 
wwrxmqefd@pharmon.biz
United States  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
194.104.8.94
zqlckzxw
 
hscvjvlou@pharmon.biz
Netherlands  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
213.108.0.68
azolkqrp
 
hrvcvtmnm@pharmon.biz
Russian Federation  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.18
amlkvpfu
 
yuzpevrsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
11-May-20 18:49
185.101.70.61
tufvuipx
 
adnntwwsu@pharmon.biz
United States  
10-May-20 02:10
5.62.158.115
jxybsglv
 
mxypksjub@pharmon.biz
United States Evidence
10-May-20 01:00
5.62.158.224
cwogmazy
 
sgqpdjfiu@pharmon.biz
United States Evidence
9-May-20 22:55
5.62.158.179
hyxvafvl
 
aznslvpvv@pharmon.biz
United States Evidence
9-May-20 20:40
5.183.252.93
geamtcrd
 
nhkyvylaw@pharmon.biz
  Evidence
9-May-20 19:05
213.108.3.134
oilzzlic
 
srcpogeph@pharmon.biz
Russian Federation Evidence
9-May-20 14:15
79.110.31.150
fjhrqdrv
 
povztfflc@pharmon.biz
Canada Evidence
9-May-20 13:50
5.62.156.22
xzudzafa
 
jxmwqjkse@pharmon.biz
United States  
9-May-20 08:50
213.108.0.113
chwqxbly
 
cwpmqvxam@pharmon.biz
Russian Federation Evidence
9-May-20 04:12
213.108.3.45
mjquswat
 
gcvhfmkvm@pharmon.biz
Russian Federation  
9-May-20 03:05
213.108.3.39
pnwkpeni
 
ffvcjwmmn@pharmon.biz
Russian Federation Evidence
9-May-20 00:25
37.9.45.229
nerqxzbj
 
gylhleqty@pharmon.biz
United States Evidence
8-May-20 23:30
5.62.156.130
udkpivbj
 
plnyhlnlx@pharmon.biz
United States  
8-May-20 20:10
194.104.8.212
jmwxqnfg
 
kvegqqnra@pharmon.biz
Netherlands Evidence
8-May-20 19:15
91.204.14.108
tbncemhc
 
grjvzpcmt@pharmon.biz
United States Evidence
8-May-20 17:25
5.183.252.85
rlxdmrmm
 
lclhuuxbk@pharmon.biz
  Evidence
8-May-20 16:03
213.108.3.220
vqpqtcwz
 
lmrkcpiec@pharmon.biz
Russian Federation  
8-May-20 15:12
213.108.3.220
vqpqtcwz
 
lmrkcpiec@pharmon.biz
Russian Federation  
8-May-20 15:10
213.108.0.137
hyoklxck
 
rdkqajlir@pharmon.biz
Russian Federation Evidence
8-May-20 13:35
5.62.153.67
qsnoxzjx
 
wkhbyxrsk@pharmon.biz
United States Evidence
8-May-20 13:28
37.9.45.210
nqnjmzrw
 
ewivigoci@pharmon.biz
United States  
8-May-20 13:28
37.9.45.210
nqnjmzrw
 
ewivigoci@pharmon.biz
United States  
8-May-20 13:28
37.9.45.210
nqnjmzrw
 
ewivigoci@pharmon.biz
United States  
8-May-20 12:20
37.9.44.162
ncxgpuhg
 
srjtarmkq@pharmon.biz
United States  
8-May-20 12:20
37.9.44.162
ncxgpuhg
 
srjtarmkq@pharmon.biz
United States  
8-May-20 12:15
213.108.3.184
fzwszigy
 
qakmqlegh@pharmon.biz
Russian Federation Evidence
8-May-20 08:22
77.220.195.252
kbdznrow
 
vtiuhidfx@pharmon.biz
Uzbekistan  
8-May-20 06:49
77.220.195.208
uwkltfsn
 
bglprbxxb@pharmon.biz
Uzbekistan  
8-May-20 06:49
77.220.195.208
uwkltfsn
 
bglprbxxb@pharmon.biz
Uzbekistan  
8-May-20 02:50
213.108.0.32
emkwcobn
 
wrkozojyb@pharmon.biz
Russian Federation Evidence
8-May-20 02:20
185.101.70.48
gnwvlwwx
 
exgkqlnqc@pharmon.biz
United States Evidence
8-May-20 01:12
77.220.195.178
jzsnidyb
 
vylzqbmfs@pharmon.biz
Uzbekistan  
8-May-20 00:10
95.85.81.30
zynfrora
 
zotuiumsa@pharmon.biz
United States Evidence
7-May-20 22:45
45.10.164.33
ktkfvicv
 
pmrogwowm@pharmon.biz
  Evidence
7-May-20 22:00
95.85.81.184
wpxwpcms
 
hedcjmwby@pharmon.biz
United States Evidence
7-May-20 15:02
37.9.44.51
mzxsunup
 
vcbciezvx@pharmon.biz
United States  
7-May-20 15:02
37.9.44.51
mzxsunup
 
vcbciezvx@pharmon.biz
United States  
7-May-20 05:15
213.108.0.247
pupiqcky
 
tlwguyhaa@pharmon.biz
Russian Federation Evidence
7-May-20 04:30
213.108.0.234
rycrftjx
 
itgsvmgxu@pharmon.biz
Russian Federation Evidence
7-May-20 04:10
185.46.85.199
ziglmjpf
 
czcijlwkn@pharmon.biz
United States Evidence
7-May-20 03:25
5.62.158.234
kowxclly
 
cajgkwwdz@pharmon.biz
United States Evidence
7-May-20 01:30
141.98.84.219
fiwsmran
 
kffgaasuo@pharmon.biz
  Evidence
7-May-20 00:20
213.108.3.101
gwmcyjbr
 
vayqnxiev@pharmon.biz
Russian Federation  
6-May-20 23:30
45.10.164.55
zvaqbata
 
urccafydz@pharmon.biz
  Evidence
6-May-20 23:25
194.104.8.101
kigfhrjs
 
stvquwkfk@pharmon.biz
Netherlands Evidence
6-May-20 12:57
213.108.0.42
tepobqyr
 
phwwrmbby@pharmon.biz
Russian Federation  
6-May-20 12:57
213.108.0.42
tepobqyr
 
phwwrmbby@pharmon.biz
Russian Federation  
6-May-20 06:30
194.104.8.51
ltmtrdip
 
wykcknbch@pharmon.biz
Netherlands Evidence
6-May-20 04:30
185.101.70.125
aftggnqg
 
xtdjhlifd@pharmon.biz
United States Evidence
6-May-20 02:17
45.10.164.21
yrvvmvdi
 
pltqbmxqz@pharmon.biz
   
6-May-20 01:20
213.108.3.204
tyxnwxmx
 
tymzzmvwp@pharmon.biz
Russian Federation Evidence
5-May-20 22:05
5.183.252.192
cfvztbtx
 
tlutixfyy@pharmon.biz
  Evidence
5-May-20 19:15
5.62.153.179
ddcyzekz
 
mzomirwko@pharmon.biz
United States Evidence
5-May-20 11:50
5.62.153.206
imwnsuij
 
kittnywbh@pharmon.biz
United States Evidence
5-May-20 11:13
213.108.3.217
qikgyroj
 
vcgcsresu@pharmon.biz
Russian Federation  
5-May-20 09:08
37.9.44.42
tfmemlxm
 
xwqmovjvv@pharmon.biz
United States  
5-May-20 09:08
37.9.44.42
tfmemlxm
 
xwqmovjvv@pharmon.biz
United States  
5-May-20 08:41
95.181.218.18
ulywcpbp
 
kuyhuocfg@pharmon.biz
United States  
5-May-20 07:53
5.62.153.226
ybofngxg
 
mgkwxpxwr@pharmon.biz
United States  
5-May-20 03:15
141.98.84.179
zpioypuy
 
ltisspvwf@pharmon.biz
  Evidence
4-May-20 17:00
5.62.156.213
edsfghxv
 
qeuyzcjkg@pharmon.biz
United States Evidence
4-May-20 15:41
95.181.218.18
ylopormn
 
plrjirswb@pharmon.biz
United States  
4-May-20 11:39
5.62.158.72
nmuroglp
 
dxoquwcko@pharmon.biz
United States  
4-May-20 11:00
5.62.156.74
pjfijshm
 
uqkgyjeaq@pharmon.biz
United States Evidence
4-May-20 09:31
5.183.252.91
kxcoxmsk
 
lkhbeuowi@pharmon.biz
   
4-May-20 09:09
77.220.195.12
jipwdjrf
 
chfxzqfaw@pharmon.biz
Uzbekistan  
4-May-20 01:40
185.46.85.52
dearzqto
 
xwuthgymg@pharmon.biz
United States Evidence
3-May-20 23:45
141.98.84.151
jsnjobay
 
eyernejek@pharmon.biz
  Evidence
3-May-20 19:35
185.46.85.37
aamvpxcb
 
njuffbhpb@pharmon.biz
United States Evidence
3-May-20 14:15
213.108.0.76
bmfyhqao
 
ipybbhhwl@pharmon.biz
Russian Federation Evidence
3-May-20 10:20
194.104.8.185
bxzceunc
 
nitfgnuhm@pharmon.biz
Netherlands Evidence
3-May-20 09:25
37.9.45.161
xatryyzm
 
ytndnoyis@pharmon.biz
United States  
3-May-20 09:25
37.9.45.161
xatryyzm
 
ytndnoyis@pharmon.biz
United States  
3-May-20 09:20
141.98.84.88
ctsgnbgh
 
yehyavjom@pharmon.biz
  Evidence
3-May-20 06:55
5.62.153.183
vlnyocqz
 
rvbcgrvxl@pharmon.biz
United States Evidence
2-May-20 15:15
45.10.164.102
ocipzdhj
 
bmoksmstu@pharmon.biz
  Evidence
2-May-20 13:46
45.10.167.199
bxwmysio
 
yjgqsftxa@pharmon.biz
   
2-May-20 13:46
45.10.167.199
bxwmysio
 
yjgqsftxa@pharmon.biz
   
2-May-20 13:46
45.10.167.199
bxwmysio
 
yjgqsftxa@pharmon.biz
   
2-May-20 12:40
37.9.44.125
bogewckk
 
lchrvwgmt@pharmon.biz
United States Evidence
2-May-20 07:50
5.62.156.83
mabgnbiv
 
ihzyyilvd@pharmon.biz
United States Evidence
2-May-20 07:00
37.9.44.131
ndymvtwx
 
uqiyfjzht@pharmon.biz
United States Evidence
2-May-20 03:10
185.101.70.202
epajdooh
 
yrhxjtsbe@pharmon.biz
United States Evidence
2-May-20 00:30
5.62.158.50
aswottos
 
qaoclqwcl@pharmon.biz
United States Evidence
1-May-20 23:06
5.62.156.68
zcbllale
 
qqdkbvjcz@pharmon.biz
United States  
1-May-20 23:03
37.9.44.140
oahkffoz
 
xovrwyzwi@pharmon.biz
United States  
1-May-20 22:50
185.101.70.228
yinvuejd
 
thyjjyqle@pharmon.biz
United States Evidence
1-May-20 13:35
95.181.218.47
wgvikrqx
 
dojxxjegy@pharmon.biz
United States Evidence
1-May-20 11:30
185.101.70.169
bdyogstr
 
rsoiuaxjt@pharmon.biz
United States Evidence
1-May-20 08:30
45.10.167.52
xzeplcbh
 
cgcetdhoh@pharmon.biz
  Evidence
1-May-20 08:25
37.9.44.221
vtgwfsbq
 
dftoxbebp@pharmon.biz
United States Evidence
30-Apr-20 18:40
45.10.164.237
aoxmpiyh
 
htifuxjyb@pharmon.biz
  Evidence
30-Apr-20 16:25
213.108.0.131
oixvmmhf
 
hqkpjepct@pharmon.biz
Russian Federation Evidence
30-Apr-20 15:05
77.220.195.152
rucmnffy
 
dhltahntc@pharmon.biz
Uzbekistan Evidence
30-Apr-20 14:50
213.108.3.38
qohiwlnt
 
cqpqfisfn@pharmon.biz
Russian Federation Evidence
30-Apr-20 14:35
5.62.153.209
mmgypjdn
 
fcvoamwzk@pharmon.biz
United States Evidence
30-Apr-20 14:30
185.46.85.238
utqnmrxn
 
jhstubvbf@pharmon.biz
United States Evidence
30-Apr-20 09:50
213.108.3.89
tittkcrm
 
ytilgwciz@pharmon.biz
Russian Federation Evidence
30-Apr-20 09:25
37.9.44.65
kfrldbzy
 
lorruhxgm@pharmon.biz
United States Evidence
30-Apr-20 09:25
45.10.164.31
nzpmijdg
 
qzmwyzqwe@pharmon.biz
  Evidence
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
45.10.167.63
atjtwcak
 
sypgawhwl@pharmon.biz
   
30-Apr-20 03:54
194.104.8.211
rstyptsr
 
nmrrqqufo@pharmon.biz
Netherlands  
29-Apr-20 01:25
77.220.192.186
pyemextm
 
tzgjbzrvn@pharmon.biz
Uzbekistan Evidence
28-Apr-20 22:45
213.108.3.101
gocssget
 
glmtvdyvn@pharmon.biz
Russian Federation Evidence
28-Apr-20 20:05
95.85.81.63
zemegfhj
 
zqsqbwrgw@pharmon.biz
United States Evidence
28-Apr-20 15:00
37.9.45.188
rriewutw
 
erteilijy@pharmon.biz
United States Evidence
28-Apr-20 14:25
5.62.153.106
cfhxpiik
 
iqhthaqmu@pharmon.biz
United States Evidence
28-Apr-20 09:05
95.181.218.107
qdselnff
 
zvqvahmhw@pharmon.biz
United States Evidence
28-Apr-20 08:26
37.9.45.105
jzhglwyw
 
jlnnfcpik@pharmon.biz
United States  
28-Apr-20 08:26
37.9.45.105
jzhglwyw
 
jlnnfcpik@pharmon.biz
United States  
28-Apr-20 08:26
37.9.45.105
jzhglwyw
 
jlnnfcpik@pharmon.biz
United States  
28-Apr-20 08:26
37.9.45.105
jzhglwyw
 
jlnnfcpik@pharmon.biz
United States  
28-Apr-20 07:55
45.10.164.146
jockwbho
 
bxxtvyzvm@pharmon.biz
  Evidence
28-Apr-20 05:10
77.220.192.21
envcqmjc
 
cdranofpi@pharmon.biz
Uzbekistan Evidence
28-Apr-20 04:30
95.85.81.19
cnisobne
 
yxlxaybvq@pharmon.biz
United States Evidence
28-Apr-20 04:30
194.104.8.30
zekgvexs
 
gucvkvldd@pharmon.biz
Netherlands Evidence
28-Apr-20 01:35
213.108.3.31
lteiwjjw
 
jyvhpgaqv@pharmon.biz
Russian Federation Evidence
27-Apr-20 23:40
194.104.8.137
kyxjczfo
 
babawiuwv@pharmon.biz
Netherlands Evidence
27-Apr-20 21:50
37.9.45.108
ygadrckr
 
jrwbhyrji@pharmon.biz
United States Evidence
27-Apr-20 17:40
185.101.70.125
tndaulay
 
nxvrjcwjv@pharmon.biz
United States Evidence
27-Apr-20 17:35
213.108.0.205
hpkyeufg
 
excvhiabl@pharmon.biz
Russian Federation Evidence
27-Apr-20 14:10
79.110.31.134
xwbulxyn
 
qvxnttbfa@pharmon.biz
Canada Evidence
27-Apr-20 12:20
185.46.85.109
szlkwfvu
 
wcnsuhdbh@pharmon.biz
United States Evidence
27-Apr-20 11:00
77.220.195.152
lxtuvdbh
 
xhurojhwh@pharmon.biz
Uzbekistan Evidence
27-Apr-20 06:55
37.9.44.166
ypuoqshm
 
josfsaibx@pharmon.biz
United States Evidence
27-Apr-20 05:10
95.85.81.182
lpfmxzwk
 
udopynhad@pharmon.biz
United States Evidence
27-Apr-20 00:15
5.62.158.218
ilthyshj
 
yvpvvamwg@pharmon.biz
United States Evidence
26-Apr-20 23:50
5.62.153.22
xusmvfgx
 
ibpadqpbf@pharmon.biz
United States Evidence
26-Apr-20 20:45
194.104.8.173
pgxfkokw
 
iknmflgyg@pharmon.biz
Netherlands Evidence
26-Apr-20 19:15
37.9.44.214
scztlnny
 
lpgpyxcqc@pharmon.biz
United States Evidence
26-Apr-20 16:50
79.110.31.201
bktvvtvi
 
wjbvjwcfs@pharmon.biz
Canada Evidence
26-Apr-20 16:45
213.108.0.183
vidnvjcu
 
sjqnpikmr@pharmon.biz
Russian Federation Evidence
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.241
kvcdbuea
 
nyhcikbrm@pharmon.biz
Russian Federation  
26-Apr-20 09:44
193.93.195.165
iyhktjfq
 
xzwoehppy@pharmon.biz
Russian Federation  
26-Apr-20 04:55
5.62.153.30
vjgaxono
 
eiixbrvka@pharmon.biz
United States Evidence
26-Apr-20 03:27
79.110.31.233
ahyysfvx
 
boyzjhlnc@pharmon.biz
Canada  
26-Apr-20 02:50
5.62.153.90
nsfdthkh
 
raxnajgnb@pharmon.biz
United States Evidence
26-Apr-20 01:15
194.104.8.101
hfmlcflw
 
stxqrcmoc@pharmon.biz
Netherlands Evidence
26-Apr-20 01:00
5.62.153.169
vpfccqrc
 
xqagbkcci@pharmon.biz
United States Evidence
26-Apr-20 00:45
77.220.195.14
meajejuw
 
acrgveila@pharmon.biz
Uzbekistan Evidence
26-Apr-20 00:40
213.108.3.221
qltthzho
 
jkmrpoggm@pharmon.biz
Russian Federation Evidence
25-Apr-20 20:00
185.46.85.111
fiqzhwxw
 
vzjhxfvyc@pharmon.biz
United States Evidence
25-Apr-20 19:40
185.101.70.124
zxljykfi
 
ajdjecyre@pharmon.biz
United States Evidence
25-Apr-20 19:40
185.46.85.182
huaxdhcb
 
zcysuacwi@pharmon.biz
United States Evidence
24-Apr-20 23:55
213.108.0.68
isfwuicp
 
vgwmkvvdd@pharmon.biz
Russian Federation Evidence
24-Apr-20 21:55
194.104.8.200
rzhrysgg
 
hulklgozt@pharmon.biz
Netherlands Evidence
24-Apr-20 20:35
213.108.0.225
ksaoyqxr
 
rhkhkqebs@pharmon.biz
Russian Federation Evidence
24-Apr-20 20:20
45.10.164.190
cmaocncr
 
iuodrhptc@pharmon.biz
  Evidence
24-Apr-20 20:10
37.9.44.54
ipmmvfab
 
qorlpuuwb@pharmon.biz
United States Evidence
24-Apr-20 20:06
213.108.0.119
ssdedelf
 
ifadqpqwa@pharmon.biz
Russian Federation  
24-Apr-20 20:05
77.220.195.208
xhrbanxr
 
ylwzndunm@pharmon.biz
Uzbekistan Evidence
24-Apr-20 18:21
37.9.45.173
ujaqedvk
 
oxmjdxtdb@pharmon.biz
United States  
24-Apr-20 18:21
194.156.124.141
yugnrscn
 
ndmczhulg@pharmon.biz
   
24-Apr-20 18:19
94.158.22.207
qigugrje
 
pkfeejemo@pharmon.biz
   
24-Apr-20 18:18
91.222.239.81
tktphrum
 
romkjywsb@pharmon.biz
Russian Federation  
24-Apr-20 18:16
45.66.208.153
hvqwaujl
 
kxofqqddm@pharmon.biz
   
24-Apr-20 14:15
45.10.167.58
lydimknl
 
erxabscdl@pharmon.biz
   
24-Apr-20 14:15
45.10.167.58
lydimknl
 
erxabscdl@pharmon.biz
   
24-Apr-20 14:10
213.108.3.246
retlwbtp
 
muvrsigtc@pharmon.biz
Russian Federation Evidence
24-Apr-20 13:50
5.62.153.152
vsdxwxub
 
fhctqxtfz@pharmon.biz
United States Evidence
24-Apr-20 13:45
185.46.85.106
gjsrvoqb
 
zvzwpzdsx@pharmon.biz
United States Evidence
24-Apr-20 10:07
213.108.3.76
bizueevp
 
xilbesdrq@pharmon.biz
Russian Federation  
24-Apr-20 08:38
45.10.167.127
syjdwaou
 
pqotxqrwe@pharmon.biz
   
24-Apr-20 07:30
185.101.70.163
zgvnrxif
 
yymlzicef@pharmon.biz
United States Evidence
24-Apr-20 04:55
213.108.3.165
tffmkjfp
 
fqllwbdzy@pharmon.biz
Russian Federation Evidence
24-Apr-20 02:44
5.62.153.17
sqfdpruc
 
wzqrufeyb@pharmon.biz
United States  
24-Apr-20 01:55
37.9.44.13
oxxlflas
 
rtkirxrqz@pharmon.biz
United States Evidence
24-Apr-20 00:37
95.181.218.19
mlmdffst
 
rphlkpuuq@pharmon.biz
United States  
23-Apr-20 21:36
37.9.44.46
ncbcviaq
 
nqvwdforq@pharmon.biz
United States  
23-Apr-20 19:03
194.104.8.204
ehdxcwas
 
ednwoqycs@pharmon.biz
Netherlands  
23-Apr-20 19:03
194.104.8.204
ehdxcwas
 
ednwoqycs@pharmon.biz
Netherlands  
23-Apr-20 18:55
79.110.31.250
qeqypktb
 
ykaquyixn@pharmon.biz
Canada Evidence
23-Apr-20 16:34
185.101.70.34
acysqmtt
 
qqimjmgml@pharmon.biz
United States  
23-Apr-20 11:53
77.220.195.216
ckjnjglx
 
bufwgulvg@pharmon.biz
Uzbekistan  
23-Apr-20 11:04
45.10.167.225
zqtynqrt
 
owplebvyz@pharmon.biz
   
23-Apr-20 10:05
213.108.3.97
guzyouuo
 
yhphuttgf@pharmon.biz
Russian Federation Evidence
23-Apr-20 09:40
77.220.195.93
tqiybewn
 
zcttehaav@pharmon.biz
Uzbekistan Evidence
23-Apr-20 07:37
213.108.3.39
madgdxrl
 
myfbqutgw@pharmon.biz
Russian Federation  
23-Apr-20 02:35
5.183.252.175
ondpgxjc
 
kjvztasrx@pharmon.biz
  Evidence
22-Apr-20 22:20
95.85.81.49
gyoeclgy
 
tumyifxkk@pharmon.biz
United States Evidence
22-Apr-20 16:35
45.10.164.70
ztddbczz
 
mdlpmhnlg@pharmon.biz
   
22-Apr-20 15:41
213.108.0.81
mntspnlj
 
iclmgjzhu@pharmon.biz
Russian Federation  
22-Apr-20 14:23
95.85.81.46
ufrktcjd
 
acvsoxzjw@pharmon.biz
United States  
22-Apr-20 09:35
5.62.156.68
oqxwmnuq
 
xmtpilgev@pharmon.biz
United States Evidence
22-Apr-20 07:12
45.10.164.247
sforbrvz
 
zzjjvkcfx@pharmon.biz
   
22-Apr-20 05:25
5.62.153.174
mtikgwnm
 
cqktmhizh@pharmon.biz
United States Evidence
22-Apr-20 01:44
5.62.156.19
uhrchaza
 
efibioszv@pharmon.biz
United States  
21-Apr-20 07:34
185.46.85.74
opnajtoj
 
iwukqbpvg@pharmon.biz
United States  
21-Apr-20 07:34
185.46.85.74
opnajtoj
 
iwukqbpvg@pharmon.biz
United States  
21-Apr-20 07:25
5.183.252.73
rcorlfau
 
tzycxadxc@pharmon.biz
  Evidence
21-Apr-20 05:05
5.183.252.85
drcdfwsr
 
ayvfllolr@pharmon.biz
  Evidence
21-Apr-20 03:15
194.104.8.59
mdeshrsi
 
pyykdptpe@pharmon.biz
Netherlands Evidence
21-Apr-20 03:10
45.10.167.163
inxuxtov
 
sislaijvg@pharmon.biz
  Evidence
21-Apr-20 02:35
37.9.44.113
wxnzsuuh
 
bufvvmmen@pharmon.biz
United States Evidence
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
21-Apr-20 02:01
37.9.45.160
yfirzywv
 
penjzepjn@pharmon.biz
United States  
20-Apr-20 09:05
5.62.158.11
eifqqnpx
 
cadwsgasl@pharmon.biz
United States Evidence
20-Apr-20 07:17
91.204.14.97
hzloegti
 
xitydltcg@pharmon.biz
United States  
20-Apr-20 07:17
91.204.14.97
hzloegti
 
xitydltcg@pharmon.biz
United States  
20-Apr-20 07:17
91.204.14.97
hzloegti
 
xitydltcg@pharmon.biz
United States  
20-Apr-20 06:25
45.10.164.252
dcgwqijw
 
yjkejllxw@pharmon.biz
  Evidence
20-Apr-20 06:00
77.220.192.72
lhbqhrlg
 
wguyckndh@pharmon.biz
Uzbekistan Evidence
20-Apr-20 03:55
194.104.8.247
hxdlhcbk
 
xthurkccm@pharmon.biz
Netherlands Evidence
20-Apr-20 03:54
37.9.44.119
edbwbzwp
 
tflittzpp@pharmon.biz
United States  
20-Apr-20 03:54
37.9.44.119
edbwbzwp
 
tflittzpp@pharmon.biz
United States  
20-Apr-20 03:54
37.9.44.119
edbwbzwp
 
tflittzpp@pharmon.biz
United States  
20-Apr-20 02:40
45.10.164.146
dbsqxgov
 
cmdllqxxy@pharmon.biz
  Evidence
20-Apr-20 00:15
37.9.44.216
rmjyuhnx
 
tdyvyfmtn@pharmon.biz
United States Evidence
19-Apr-20 21:04
37.9.44.12
sykspwpy
 
kibsnhebc@pharmon.biz
United States  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 19:42
213.108.0.74
olsrypuk
 
bmjldsssp@pharmon.biz
Russian Federation  
19-Apr-20 15:33
213.108.3.69
xnnrrmxm
 
yvygqjwtn@pharmon.biz
Russian Federation  
19-Apr-20 13:30
5.62.158.12
rvbfjnpr
 
ahwwhvghg@pharmon.biz
United States Evidence
19-Apr-20 08:46
194.104.8.28
anhbiiku
 
pvcdozumh@pharmon.biz
Netherlands  
19-Apr-20 08:15
5.183.252.20
plmnzkxj
 
mdwjmohwb@pharmon.biz
  Evidence
19-Apr-20 06:35
37.9.45.27
cneawjmp
 
avlpjiqzr@pharmon.biz
United States Evidence
19-Apr-20 06:28
37.9.44.23
rkrfnang
 
cncbdbmda@pharmon.biz
United States  
19-Apr-20 06:28
37.9.44.23
rkrfnang
 
cncbdbmda@pharmon.biz
United States  
18-Apr-20 18:49
77.220.192.220
hreiqfue
 
lnxzlmmfv@pharmon.biz
Uzbekistan  
18-Apr-20 18:49
77.220.192.220
hreiqfue
 
lnxzlmmfv@pharmon.biz
Uzbekistan  
18-Apr-20 18:43
95.85.81.39
qhynutje
 
bkawotwno@pharmon.biz
United States  
18-Apr-20 17:07
77.220.192.129
xrxkovwp
 
psdjxzimy@pharmon.biz
Uzbekistan  
18-Apr-20 13:40
91.204.14.27
cqdojzus
 
ktpyoblgx@pharmon.biz
United States Evidence
18-Apr-20 13:05
5.183.252.154
fnpokuwl
 
kytmhmtgd@pharmon.biz
  Evidence
18-Apr-20 11:05
37.9.45.189
rekelecm
 
yphkenils@pharmon.biz
United States Evidence
18-Apr-20 08:54
185.101.70.141
qoahmita
 
brjqdnacf@pharmon.biz
United States  
18-Apr-20 08:12
5.62.156.213
mclqtiqd
 
yxrxussfr@pharmon.biz
United States  
18-Apr-20 08:00
185.46.85.20
dwfappwi
 
uxbearuql@pharmon.biz
United States Evidence
18-Apr-20 07:25
77.220.195.75
qflhvfkc
 
dhmkjegqq@pharmon.biz
Uzbekistan Evidence
18-Apr-20 06:41
141.98.84.127
qntjiezj
 
srloanftw@pharmon.biz
   
18-Apr-20 06:13
45.10.167.24
qyegseql
 
vwsorworv@pharmon.biz
   
18-Apr-20 02:40
77.220.192.238
lkhbmwgy
 
accbobxcx@pharmon.biz
Uzbekistan Evidence
18-Apr-20 01:10
37.9.44.131
tkqylrfy
 
eddrvlcme@pharmon.biz
United States Evidence
17-Apr-20 22:48
77.220.195.131
azkvthto
 
wnnpkfdku@pharmon.biz
Uzbekistan  
17-Apr-20 21:15
5.62.153.26
kzjthjfg
 
njviufqox@pharmon.biz
United States Evidence
17-Apr-20 17:50
37.9.44.216
ayadzbnd
 
ytvanjcfk@pharmon.biz
United States  
17-Apr-20 17:10
45.10.164.116
hslqkcra
 
whnseovvy@pharmon.biz
  Evidence
17-Apr-20 16:26
37.9.44.50
srhpnnfy
 
llpgwofxr@pharmon.biz
United States  
17-Apr-20 16:26
37.9.44.50
srhpnnfy
 
llpgwofxr@pharmon.biz
United States  
17-Apr-20 16:15
45.10.167.117
wuucfmqj
 
fklswnfyk@pharmon.biz
  Evidence
17-Apr-20 14:40
141.98.84.66
gyycdizf
 
uwqdmatkq@pharmon.biz
   
17-Apr-20 12:20
5.62.158.92
rjsaxjua
 
btchyafkv@pharmon.biz
United States Evidence
17-Apr-20 11:45
194.104.8.73
sjjsbwhr
 
sjqvrryae@pharmon.biz
Netherlands  
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 07:12
141.98.84.36
wgmmylie
 
fgxnxjqln@pharmon.biz
   
17-Apr-20 02:05
185.101.70.54
qslhnpvp
 
kdveedzfh@pharmon.biz
United States Evidence
17-Apr-20 00:15
37.9.45.147
aeisyexf
 
rwbebdzga@pharmon.biz
United States Evidence
16-Apr-20 23:10
213.108.3.85
itwxlonj
 
pbgnrdtwm@pharmon.biz
Russian Federation  
16-Apr-20 21:30
5.62.156.99
ttgxryyt
 
qhcdktwdl@pharmon.biz
United States Evidence
16-Apr-20 20:45
185.101.70.159
smfaioql
 
eyrgekkar@pharmon.biz
United States Evidence
16-Apr-20 17:05
5.183.252.105
ymhhruje
 
yapawvesu@pharmon.biz
   
16-Apr-20 14:30
185.46.85.212
nsmhhhvm
 
pvuvvcmvu@pharmon.biz
United States  
16-Apr-20 14:03
185.46.85.224
pzhttzkr
 
oqisnzlgb@pharmon.biz
United States  
16-Apr-20 13:45
185.46.85.253
qhzctdso
 
vnloyqbik@pharmon.biz
United States Evidence
16-Apr-20 13:00
194.104.8.208
pwdcmesx
 
tlgjyvjga@pharmon.biz
Netherlands Evidence
16-Apr-20 08:25
45.10.164.249
wwmsybbw
 
ywvaqepow@pharmon.biz
  Evidence
16-Apr-20 05:44
5.62.158.44
lnbgjkqm
 
ntgubpyni@pharmon.biz
United States  
16-Apr-20 05:44
5.62.158.44
lnbgjkqm
 
ntgubpyni@pharmon.biz
United States  
16-Apr-20 05:44
5.62.158.44
lnbgjkqm
 
ntgubpyni@pharmon.biz
United States  
16-Apr-20 05:44
5.62.158.44
lnbgjkqm
 
ntgubpyni@pharmon.biz
United States  
16-Apr-20 05:25
185.46.85.69
udsrknbe
 
rgujitdzi@pharmon.biz
United States Evidence
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
16-Apr-20 01:47
79.110.31.239
inlbfwxc
 
exzchernq@pharmon.biz
Canada  
15-Apr-20 23:03
77.220.195.12
dwcxpgtv
 
xfrrseazu@pharmon.biz
Uzbekistan  
15-Apr-20 22:15
77.220.192.37
qutzvcle
 
dsltyiqdi@pharmon.biz
Uzbekistan Evidence
15-Apr-20 22:10
185.46.85.23
sfctzpjs
 
ihraowhic@pharmon.biz
United States Evidence
15-Apr-20 20:25
141.98.84.142
tqqhrxhk
 
qqxhgxgdt@pharmon.biz
   
15-Apr-20 20:25
141.98.84.142
tqqhrxhk
 
qqxhgxgdt@pharmon.biz
   
15-Apr-20 15:45
77.220.192.13
ioshaguo
 
jkchdodoi@pharmon.biz
Uzbekistan Evidence
15-Apr-20 14:50
141.98.84.126
emogemej
 
hyaxrikjg@pharmon.biz
  Evidence
15-Apr-20 14:47
185.101.70.187
naancnzd
 
qjsxlsjwz@pharmon.biz
United States  
15-Apr-20 14:47
185.101.70.187
naancnzd
 
qjsxlsjwz@pharmon.biz
United States  
15-Apr-20 14:46
213.108.3.31
swehiuvh
 
qieutkzai@pharmon.biz
Russian Federation  
15-Apr-20 14:46
213.108.3.31
swehiuvh
 
qieutkzai@pharmon.biz
Russian Federation  
15-Apr-20 14:46
213.108.3.31
swehiuvh
 
qieutkzai@pharmon.biz
Russian Federation  
15-Apr-20 14:46
213.108.3.31
swehiuvh
 
qieutkzai@pharmon.biz
Russian Federation  
15-Apr-20 13:34
5.183.252.141
dfedishk
 
gvmjvboap@pharmon.biz
   
15-Apr-20 13:34
5.183.252.141
dfedishk
 
gvmjvboap@pharmon.biz
   
15-Apr-20 13:34
5.183.252.141
dfedishk
 
gvmjvboap@pharmon.biz
   
15-Apr-20 13:34
5.183.252.141
dfedishk
 
gvmjvboap@pharmon.biz
   
15-Apr-20 13:34
5.183.252.141
dfedishk
 
gvmjvboap@pharmon.biz
   
15-Apr-20 13:34
213.108.0.148
qrdxiwcq
 
zkrmopcye@pharmon.biz
Russian Federation  
15-Apr-20 13:34
213.108.0.148
qrdxiwcq
 
zkrmopcye@pharmon.biz
Russian Federation  
15-Apr-20 13:05
37.9.44.47
tpxrrsjz
 
lahwrgnyp@pharmon.biz
United States Evidence
15-Apr-20 10:39
45.10.164.225
qbmgmbid
 
dncoopclm@pharmon.biz
   
15-Apr-20 09:00
5.62.158.18
uvwaammq
 
kkcoastou@pharmon.biz
United States  
15-Apr-20 09:00
5.62.158.18
uvwaammq
 
kkcoastou@pharmon.biz
United States  
15-Apr-20 08:09
91.204.14.59
uniogjyo
 
njthxsvny@pharmon.biz
United States  
15-Apr-20 08:09
91.204.14.59
uniogjyo
 
njthxsvny@pharmon.biz
United States  
15-Apr-20 08:09
91.204.14.59
uniogjyo
 
njthxsvny@pharmon.biz
United States  
15-Apr-20 08:09
91.204.14.59
uniogjyo
 
njthxsvny@pharmon.biz
United States  
15-Apr-20 08:07
37.9.45.43
jfzwonsd
 
edxglasmq@pharmon.biz
United States  
15-Apr-20 08:07
37.9.45.43
jfzwonsd
 
edxglasmq@pharmon.biz
United States  
15-Apr-20 08:07
37.9.45.43
jfzwonsd
 
edxglasmq@pharmon.biz
United States  
15-Apr-20 08:07
37.9.45.43
jfzwonsd
 
edxglasmq@pharmon.biz
United States  
15-Apr-20 08:07
37.9.45.43
jfzwonsd
 
edxglasmq@pharmon.biz
United States  
15-Apr-20 07:40
91.204.14.23
pcgheggw
 
aqabzeeqj@pharmon.biz
United States Evidence
15-Apr-20 07:03
185.101.70.31
appkpffe
 
efhuhqjii@pharmon.biz
United States  
15-Apr-20 07:03
185.101.70.31
appkpffe
 
efhuhqjii@pharmon.biz
United States  
15-Apr-20 03:19
213.108.0.74
mtdpyiel
 
lnyhzugdl@pharmon.biz
Russian Federation  
15-Apr-20 03:19
77.220.192.53
cfizhcud
 
jncidrgsk@pharmon.biz
Uzbekistan  
15-Apr-20 02:04
185.101.70.220
hvfnronu
 
xfkohyprx@pharmon.biz
United States  
15-Apr-20 01:04
5.62.158.126
ifxwccjh
 
benayoguc@pharmon.biz
United States  
15-Apr-20 00:39
213.108.3.101
nmftxwii
 
fffatzzsn@pharmon.biz
Russian Federation  
14-Apr-20 23:38
194.104.8.224
urwyarnh
 
xxaqqddbl@pharmon.biz
Netherlands  
14-Apr-20 22:55
45.10.167.57
fhbfmaes
 
clbmowdet@pharmon.biz
   
14-Apr-20 22:55
45.10.167.57
fhbfmaes
 
clbmowdet@pharmon.biz
   
14-Apr-20 22:55
79.110.31.225
leeujepl
 
upfysbqpk@pharmon.biz
Canada  
14-Apr-20 19:19
95.181.218.18
urfxaxzb
 
wvdtcbfbp@pharmon.biz
United States  
14-Apr-20 19:19
95.181.218.18
urfxaxzb
 
wvdtcbfbp@pharmon.biz
United States  
14-Apr-20 19:19
95.181.218.18
urfxaxzb
 
wvdtcbfbp@pharmon.biz
United States  
14-Apr-20 18:27
45.10.164.102
pijydqkh
 
ossikerwd@pharmon.biz
   
14-Apr-20 16:38
91.204.14.25
almiyvzw
 
jmsyaouyp@pharmon.biz
United States  
14-Apr-20 16:38
91.204.14.25
almiyvzw
 
jmsyaouyp@pharmon.biz
United States  
14-Apr-20 16:38
91.204.14.25
almiyvzw
 
jmsyaouyp@pharmon.biz
United States  
14-Apr-20 16:38
91.204.14.25
almiyvzw
 
jmsyaouyp@pharmon.biz
United States  
14-Apr-20 16:38
91.204.14.25
almiyvzw
 
jmsyaouyp@pharmon.biz
United States  
14-Apr-20 15:36
92.38.139.226
kjcpzgep
 
coekagzrw@pharmon.biz
Russian Federation  
14-Apr-20 15:06
5.62.156.109
zzietjfj
 
jeteqdavn@pharmon.biz
United States  
14-Apr-20 15:06
5.62.156.109
zzietjfj
 
jeteqdavn@pharmon.biz
United States  
14-Apr-20 14:10
5.183.252.110
xdkirnnr
 
oeggyseki@pharmon.biz
   
14-Apr-20 14:10
77.220.195.61
eaydyffe
 
tfmobajgq@pharmon.biz
Uzbekistan  
14-Apr-20 12:50
5.62.153.172
pocojykg
 
ozvmkycfz@pharmon.biz
United States  
14-Apr-20 12:14
141.98.84.244
jvjwdijr
 
eihzipayy@pharmon.biz
   
14-Apr-20 12:14
141.98.84.244
jvjwdijr
 
eihzipayy@pharmon.biz
   
14-Apr-20 12:14
141.98.84.244
jvjwdijr
 
eihzipayy@pharmon.biz
   
14-Apr-20 12:14
194.104.8.253
yqvxhcxf
 
fmhiqnfpq@pharmon.biz
Netherlands  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
77.220.192.181
fvgzjokm
 
ntwepgmrn@pharmon.biz
Uzbekistan  
14-Apr-20 07:58
5.62.156.130
kunxauxt
 
hyjbfddmh@pharmon.biz
United States  
14-Apr-20 07:58
5.62.156.130
kunxauxt
 
hyjbfddmh@pharmon.biz
United States  
14-Apr-20 07:58
5.62.156.130
kunxauxt
 
hyjbfddmh@pharmon.biz
United States  
14-Apr-20 07:58
5.62.156.130
kunxauxt
 
hyjbfddmh@pharmon.biz
United States  
14-Apr-20 06:49
213.108.0.124
gevavjei
 
gzjhugayh@pharmon.biz
Russian Federation  
14-Apr-20 06:23
213.108.0.48
qmfclrik
 
sdidpkleo@pharmon.biz
Russian Federation  
14-Apr-20 06:17
45.10.167.230
nwldpvkw
 
vmngbvbgj@pharmon.biz
   
14-Apr-20 04:49
45.10.164.209
edcnltlk
 
suopxoeeb@pharmon.biz
   
14-Apr-20 04:49
45.10.164.209
edcnltlk
 
suopxoeeb@pharmon.biz
   
14-Apr-20 02:50
77.220.192.220
bjowaqcg
 
qoexhfpwv@pharmon.biz
Uzbekistan  
14-Apr-20 02:15
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:15
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:15
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:14
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:14
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:14
194.104.8.246
unpibtlf
 
gfugwspaz@pharmon.biz
Netherlands  
14-Apr-20 02:01
95.181.218.92
ifqekevz
 
cezppcizu@pharmon.biz
United States  
14-Apr-20 02:01
95.181.218.92
ifqekevz
 
cezppcizu@pharmon.biz
United States  
14-Apr-20 01:14
213.108.0.245
uhozxzna
 
aoydmluem@pharmon.biz
Russian Federation  
14-Apr-20 01:14
5.62.153.53
mjgolnrn
 
qxnuprwlc@pharmon.biz
United States  
14-Apr-20 00:39
194.104.8.92
yozrjmbs
 
edsjuluqc@pharmon.biz
Netherlands  
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
45.10.164.148
wjtzbnpe
 
ogbyjzhyx@pharmon.biz
   
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 23:57
5.62.158.174
pljfoujm
 
guytqytpx@pharmon.biz
United States  
13-Apr-20 22:18
37.9.44.21
vjtiqntz
 
lguvwcxwr@pharmon.biz
United States  
13-Apr-20 21:50
5.183.252.60
sdwvfquf
 
seozvrxxc@pharmon.biz
  Evidence
13-Apr-20 21:46
77.220.195.21
gnhemiia
 
ygfeegsgm@pharmon.biz
Uzbekistan  
13-Apr-20 21:13
185.101.70.92
yiydpndl
 
izimbdxlo@pharmon.biz
United States Evidence
13-Apr-20 19:01
45.10.164.116
vqhyrjyo
 
xcabudbyc@pharmon.biz
   
13-Apr-20 19:01
5.62.153.194
edycxsds
 
wcsdbribd@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:44
37.9.44.110
uyiohpma
 
ddlhhpklz@pharmon.biz
United States  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
213.108.3.102
ajuyhisc
 
vakfisrcs@pharmon.biz
Russian Federation  
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
45.10.164.179
bidiirze
 
kejbgnoku@pharmon.biz
   
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.225
zhemztnt
 
ccnbxzdct@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
5.62.158.62
auldqszf
 
ofgdxjgpv@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.108
tfpbwvkm
 
exxrbmlbl@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.108
tfpbwvkm
 
exxrbmlbl@pharmon.biz
United States  
13-Apr-20 17:43
185.46.85.108
tfpbwvkm
 
exxrbmlbl@pharmon.biz
United States  
13-Apr-20 16:32
185.46.85.23
umlnceox
 
gzscahoip@pharmon.biz
United States  
13-Apr-20 16:28
5.62.156.109
tqyqhidd
 
mbzixqzmp@pharmon.biz
United States  
13-Apr-20 15:40
194.104.8.190
hxthltor
 
kmkpvhaaq@pharmon.biz
Netherlands  
13-Apr-20 15:40
194.104.8.190
hxthltor
 
kmkpvhaaq@pharmon.biz
Netherlands  
13-Apr-20 15:40
194.104.8.190
hxthltor
 
kmkpvhaaq@pharmon.biz
Netherlands  
13-Apr-20 14:59
185.46.85.182
dcavonmt
 
kwjinwvwe@pharmon.biz
United States  
13-Apr-20 14:22
141.98.84.57
ufppazry
 
zfhzulmru@pharmon.biz
   
13-Apr-20 14:22
141.98.84.57
ufppazry
 
zfhzulmru@pharmon.biz
   
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
5.62.156.223
amnhsmvi
 
zxbthimyr@pharmon.biz
United States  
13-Apr-20 13:42
213.108.0.146
rqzueqev
 
goszdgpfk@pharmon.biz
Russian Federation  
13-Apr-20 13:42
213.108.0.146
rqzueqev
 
goszdgpfk@pharmon.biz
Russian Federation  
13-Apr-20 13:41
45.10.164.101
pdlzezwh
 
cxfgrtmuv@pharmon.biz
   
13-Apr-20 13:41
45.10.164.101
pdlzezwh
 
cxfgrtmuv@pharmon.biz
   
13-Apr-20 13:41
77.220.192.241
xnjvhmbv
 
dyyhqtepr@pharmon.biz
Uzbekistan  
13-Apr-20 13:41
77.220.192.241
xnjvhmbv
 
dyyhqtepr@pharmon.biz
Uzbekistan  
13-Apr-20 13:31
141.98.84.113
xsfoekji
 
jrwzpumyw@pharmon.biz
   
13-Apr-20 13:31
141.98.84.113
xsfoekji
 
jrwzpumyw@pharmon.biz
   
13-Apr-20 13:31
141.98.84.113
xsfoekji
 
jrwzpumyw@pharmon.biz
   
13-Apr-20 13:31
141.98.84.113
xsfoekji
 
jrwzpumyw@pharmon.biz
   
13-Apr-20 13:31
141.98.84.113
xsfoekji
 
jrwzpumyw@pharmon.biz
   
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:31
79.110.31.207
bqyqoaqj
 
rvxsijeve@pharmon.biz
Canada  
13-Apr-20 13:05
185.46.85.216
pucfcztb
 
hbqvmvlxz@pharmon.biz
United States  
13-Apr-20 13:05
185.46.85.216
pucfcztb
 
hbqvmvlxz@pharmon.biz
United States  
13-Apr-20 12:53
5.62.158.161
yqaysvml
 
ubpuyuviy@pharmon.biz
United States  
13-Apr-20 12:53
5.62.158.161
yqaysvml
 
ubpuyuviy@pharmon.biz
United States  
13-Apr-20 10:20
95.85.81.112
autjhdml
 
wgyjxtqil@pharmon.biz
United States  
13-Apr-20 09:48
185.46.85.14
yqjtbrrn
 
ogamgazsf@pharmon.biz
United States  
13-Apr-20 08:12
95.181.218.101
zpmbfgdy
 
njtomlcyy@pharmon.biz
United States  
13-Apr-20 08:12
95.181.218.101
zpmbfgdy
 
njtomlcyy@pharmon.biz
United States  
13-Apr-20 07:57
5.62.153.209
lrsvrnvt
 
uovrkhpsm@pharmon.biz
United States  
13-Apr-20 07:36
213.108.3.144
aobgegkk
 
jtrzbuwnc@pharmon.biz
Russian Federation Evidence
13-Apr-20 07:27
213.108.0.237
iinlwjnn
 
pxfettzex@pharmon.biz
Russian Federation  
13-Apr-20 05:00
213.108.3.221
tnpkqzbz
 
ydfdaoaun@pharmon.biz
Russian Federation  
13-Apr-20 05:00
213.108.3.221
tnpkqzbz
 
ydfdaoaun@pharmon.biz
Russian Federation  
13-Apr-20 04:57
213.108.0.42
plsmerjv
 
kbyawwflz@pharmon.biz
Russian Federation  
13-Apr-20 04:57
213.108.0.42
plsmerjv
 
kbyawwflz@pharmon.biz
Russian Federation  
13-Apr-20 04:57
213.108.0.42
plsmerjv
 
kbyawwflz@pharmon.biz
Russian Federation  
13-Apr-20 04:54
77.220.192.171
riquiybw
 
vykejwens@pharmon.biz
Uzbekistan  
13-Apr-20 04:53
79.110.31.135
ueatemdr
 
fapnnnsah@pharmon.biz
Canada  
13-Apr-20 04:53
79.110.31.135
ueatemdr
 
fapnnnsah@pharmon.biz
Canada  
13-Apr-20 04:08
5.183.252.68
mffdsojh
 
fairxgruh@pharmon.biz
   
13-Apr-20 04:08
5.183.252.68
mffdsojh
 
fairxgruh@pharmon.biz
   
13-Apr-20 02:40
45.10.167.88
ffivtypf
 
gbsepeggf@pharmon.biz
   
13-Apr-20 02:40
45.10.167.88
ffivtypf
 
gbsepeggf@pharmon.biz
   
13-Apr-20 01:22
213.108.3.133
jlzuufvs
 
xkwdcljlb@pharmon.biz
Russian Federation  
13-Apr-20 01:10
5.62.158.12
jlsznfqf
 
ndyuiapsh@pharmon.biz
United States  
13-Apr-20 00:34
77.220.192.238
ujsdnbyk
 
tkfhkjtze@pharmon.biz
Uzbekistan  
13-Apr-20 00:34
77.220.192.238
ujsdnbyk
 
tkfhkjtze@pharmon.biz
Uzbekistan  
12-Apr-20 21:00
185.101.70.209
dyrwobfw
 
xtfjswqkr@pharmon.biz
United States Evidence
12-Apr-20 19:30
213.108.0.159
jimbycbd
 
mofswuphw@pharmon.biz
Russian Federation  
12-Apr-20 19:28
37.9.45.190
dofifmli
 
houxjlxqh@pharmon.biz
United States  
12-Apr-20 19:24
5.62.158.58
rgymyeor
 
krxznohdy@pharmon.biz
United States  
12-Apr-20 19:19
77.220.195.63
kirhossp
 
lnpxpdtds@pharmon.biz
Uzbekistan  
12-Apr-20 17:01
95.181.218.88
scuymrvi
 
oghpextmx@pharmon.biz
United States  
12-Apr-20 16:30
37.9.45.121
khodrmtn
 
ldfgpmwyw@pharmon.biz
United States  
12-Apr-20 16:30
37.9.45.121
khodrmtn
 
ldfgpmwyw@pharmon.biz
United States  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:30
77.220.195.75
kkfxrkig
 
evfkpiwhp@pharmon.biz
Uzbekistan  
12-Apr-20 16:29
45.10.164.20
ftpsktph
 
ivsapmeuz@pharmon.biz
   
12-Apr-20 16:29
45.10.164.20
ftpsktph
 
ivsapmeuz@pharmon.biz
   
12-Apr-20 16:29
45.10.164.20
ftpsktph
 
ivsapmeuz@pharmon.biz
   
12-Apr-20 16:27
77.220.192.227
xhmwnfko
 
raxeptqgm@pharmon.biz
Uzbekistan  
12-Apr-20 15:51
77.220.195.158
gklojfjq
 
mlslmgevi@pharmon.biz
Uzbekistan  
12-Apr-20 15:28
5.62.156.54
tkdyoidt
 
nqxoiyrzw@pharmon.biz
United States  
12-Apr-20 15:04
45.10.164.30
gifebjgm
 
gmkepmesx@pharmon.biz
  Evidence
12-Apr-20 12:54
95.85.81.109
unvslkpb
 
xczbywsnz@pharmon.biz
United States  
12-Apr-20 12:03
5.62.153.28
djuuscfr
 
tgitquslm@pharmon.biz
United States  
12-Apr-20 06:57
37.9.45.174
fkaelkjl
 
tktvjhmnt@pharmon.biz
United States  
12-Apr-20 06:49
77.220.195.152
qimewflx
 
qvkimwivs@pharmon.biz
Uzbekistan  
12-Apr-20 05:06
141.98.84.57
wrpbtnmm
 
hslyedipb@pharmon.biz
   
12-Apr-20 04:59
185.46.85.52
giymgccn
 
rlrtaqnlr@pharmon.biz
United States  
12-Apr-20 03:24
95.85.81.26
dkbruayz
 
zxcefrwjm@pharmon.biz
United States  
12-Apr-20 03:11
185.46.85.105
ugedgfhb
 
osvozkxud@pharmon.biz
United States  
12-Apr-20 03:11
185.46.85.105
ugedgfhb
 
osvozkxud@pharmon.biz
United States  
12-Apr-20 02:43
5.62.153.217
vmdvnhlz
 
kmjzlsguh@pharmon.biz
United States  
12-Apr-20 02:43
5.62.153.217
vmdvnhlz
 
kmjzlsguh@pharmon.biz
United States  
12-Apr-20 02:21
185.46.85.45
rcotxyxh
 
yaizyvbke@pharmon.biz
United States  
12-Apr-20 02:21
185.46.85.45
rcotxyxh
 
yaizyvbke@pharmon.biz
United States  
12-Apr-20 01:38
213.108.0.231
ixbmzscy
 
edqavvzzf@pharmon.biz
Russian Federation  
12-Apr-20 01:02
213.108.0.241
hgdvvzqf
 
bjpwlbqop@pharmon.biz
Russian Federation  
12-Apr-20 00:05
5.62.158.64
uvhrzplo
 
dmlynycqb@pharmon.biz
United States Evidence
11-Apr-20 22:25
77.220.192.62
yrhxvubs
 
uupdpgoas@pharmon.biz
Uzbekistan Evidence
11-Apr-20 21:15
37.9.44.80
jmyvphtl
 
fvcgypggi@pharmon.biz
United States  
11-Apr-20 21:05
45.10.167.220
qkvtjmjx
 
ddwobnjsf@pharmon.biz
   
11-Apr-20 21:00
194.104.8.204
azuhasqq
 
qpdzfmgmw@pharmon.biz
Netherlands  
11-Apr-20 21:00
194.104.8.204
azuhasqq
 
qpdzfmgmw@pharmon.biz
Netherlands  
11-Apr-20 21:00
194.104.8.204
azuhasqq
 
qpdzfmgmw@pharmon.biz
Netherlands  
11-Apr-20 21:00
194.104.8.204
azuhasqq
 
qpdzfmgmw@pharmon.biz
Netherlands  
11-Apr-20 21:00
194.104.8.204
azuhasqq
 
qpdzfmgmw@pharmon.biz
Netherlands  
11-Apr-20 19:39
37.9.44.96
wqhgsjja
 
duvvgoejv@pharmon.biz
United States  
11-Apr-20 18:36
92.38.139.226
vqofirwn
 
unagjizpc@pharmon.biz
Russian Federation  
11-Apr-20 18:36
92.38.139.226
vqofirwn
 
unagjizpc@pharmon.biz
Russian Federation  
11-Apr-20 18:36
92.38.139.226
vqofirwn
 
unagjizpc@pharmon.biz
Russian Federation  
11-Apr-20 18:36
92.38.139.226
vqofirwn
 
unagjizpc@pharmon.biz
Russian Federation  
11-Apr-20 17:29
79.110.31.135
yspxmlqd
 
qbydfwdqk@pharmon.biz
Canada  
11-Apr-20 17:29
79.110.31.135
yspxmlqd
 
qbydfwdqk@pharmon.biz
Canada  
11-Apr-20 16:58
141.98.84.151
vhkqmihh
 
zavnxmlwu@pharmon.biz
   
11-Apr-20 16:58
141.98.84.151
vhkqmihh
 
zavnxmlwu@pharmon.biz
   
11-Apr-20 16:58
141.98.84.151
vhkqmihh
 
zavnxmlwu@pharmon.biz
   
11-Apr-20 16:21
45.10.167.236
ndgyegqa
 
eudmcxezn@pharmon.biz
   
11-Apr-20 16:10
37.9.44.61
jtnpshxn
 
vmxvyuchy@pharmon.biz
United States  
11-Apr-20 16:03
79.110.31.216
sapkzrhd
 
mbqfoniuq@pharmon.biz
Canada  
11-Apr-20 16:03
79.110.31.216
sapkzrhd
 
mbqfoniuq@pharmon.biz
Canada  
11-Apr-20 16:03
79.110.31.216
sapkzrhd
 
mbqfoniuq@pharmon.biz
Canada  
11-Apr-20 16:03
5.62.158.220
kftcmkum
 
vbwyxdhuj@pharmon.biz
United States  
11-Apr-20 16:03
5.62.158.220
kftcmkum
 
vbwyxdhuj@pharmon.biz
United States  
11-Apr-20 14:37
45.10.167.229
tjawhlqy
 
azwhbkdtz@pharmon.biz
   
11-Apr-20 13:56
77.220.195.207
kyjhpfaf
 
spguajrrp@pharmon.biz
Uzbekistan  
11-Apr-20 13:56
77.220.195.207
kyjhpfaf
 
spguajrrp@pharmon.biz
Uzbekistan  
11-Apr-20 13:53
45.10.164.128
nbdegxuu
 
ubmrzeojl@pharmon.biz
   
11-Apr-20 13:53
45.10.164.128
nbdegxuu
 
ubmrzeojl@pharmon.biz
   
11-Apr-20 13:12
95.181.218.16
slbhgbow
 
gwxhavqhi@pharmon.biz
United States  
11-Apr-20 13:12
95.181.218.16
slbhgbow
 
gwxhavqhi@pharmon.biz
United States  
11-Apr-20 11:18
79.110.31.176
ltcixyxt
 
hseypqpdw@pharmon.biz
Canada  
11-Apr-20 11:18
79.110.31.176
ltcixyxt
 
hseypqpdw@pharmon.biz
Canada  
11-Apr-20 10:48
5.183.252.93
xbeevtme
 
iadwkuaeg@pharmon.biz
   
11-Apr-20 09:38
91.204.14.108
nmrqtkky
 
ydkoqjnxj@pharmon.biz
United States  
11-Apr-20 09:06
213.108.3.38
vvjsfccj
 
ixyefmoag@pharmon.biz
Russian Federation  
11-Apr-20 09:06
5.62.153.193
rdyprlje
 
sdmseiboq@pharmon.biz
United States  
11-Apr-20 09:06
77.220.195.116
rfcbybei
 
iyyagylkt@pharmon.biz
Uzbekistan  
11-Apr-20 09:02
141.98.84.67
sydlaskx
 
zgmobxalw@pharmon.biz
   
11-Apr-20 09:02
141.98.84.67
sydlaskx
 
zgmobxalw@pharmon.biz
   
11-Apr-20 09:02
213.108.3.38
vvjsfccj
 
ixyefmoag@pharmon.biz
Russian Federation  
11-Apr-20 09:01
5.62.158.12
kyzblsdp
 
rypsnphkn@pharmon.biz
United States  
11-Apr-20 09:01
213.108.3.38
vvjsfccj
 
ixyefmoag@pharmon.biz
Russian Federation  
11-Apr-20 09:01
5.62.153.193
rdyprlje
 
sdmseiboq@pharmon.biz
United States  
11-Apr-20 09:00
77.220.195.116
rfcbybei
 
iyyagylkt@pharmon.biz
Uzbekistan  
11-Apr-20 06:47
77.220.195.116
rfcbybei
 
iyyagylkt@pharmon.biz
Uzbekistan  
11-Apr-20 06:47
77.220.195.116
rfcbybei
 
iyyagylkt@pharmon.biz
Uzbekistan  
11-Apr-20 05:07
5.62.156.83
psivorst
 
afmamwblp@pharmon.biz
United States  
11-Apr-20 02:36
77.220.195.46
euhzhvff
 
yilomjblh@pharmon.biz
Uzbekistan  
10-Apr-20 22:32
45.10.164.247
fhkugpmp
 
bpgeqadbr@pharmon.biz
   
10-Apr-20 20:25
37.9.45.46
hxiidotd
 
zabuoctug@pharmon.biz
United States  
10-Apr-20 20:25
37.9.45.46
hxiidotd
 
zabuoctug@pharmon.biz
United States  
10-Apr-20 16:53
92.38.139.226
xdwdzjyu
 
arabqakyk@pharmon.biz
Russian Federation  
10-Apr-20 13:47
141.98.84.252
oysqhtil
 
zvawmaqxw@pharmon.biz
   
10-Apr-20 12:32
141.98.84.252
rxloexyg
 
ahqwyoifb@pharmon.biz
   
10-Apr-20 12:32
141.98.84.252
rxloexyg
 
ahqwyoifb@pharmon.biz
   
10-Apr-20 10:45
95.85.81.15
uboisixs
 
pfnhagkmx@pharmon.biz
United States  
10-Apr-20 09:26
5.62.153.32
wjwigjrc
 
mtwddstka@pharmon.biz
United States  
10-Apr-20 07:40
194.104.8.226
sbcmhufy
 
kaaishtyz@pharmon.biz
Netherlands  
10-Apr-20 07:40
194.104.8.226
sbcmhufy
 
kaaishtyz@pharmon.biz
Netherlands  
10-Apr-20 06:11
79.110.31.191
cpsynpzh
 
xaussgygx@pharmon.biz
Canada  
10-Apr-20 06:11
79.110.31.191
cpsynpzh
 
xaussgygx@pharmon.biz
Canada  
10-Apr-20 02:40
141.98.84.50
xrnfwnbm
 
dqbkbitwz@pharmon.biz
   
10-Apr-20 02:40
141.98.84.50
xrnfwnbm
 
dqbkbitwz@pharmon.biz
   
10-Apr-20 00:44
185.101.70.173
qcykslwu
 
dmqjqoyhc@pharmon.biz
United States  
10-Apr-20 00:39
213.108.3.124
vcfwyene
 
jodfenzuh@pharmon.biz
Russian Federation  
9-Apr-20 22:17
5.62.156.121
fjsmxvwc
 
nzgpgmtjc@pharmon.biz
United States  
9-Apr-20 22:17
5.62.156.121
fjsmxvwc
 
nzgpgmtjc@pharmon.biz
United States  
9-Apr-20 22:17
5.62.156.121
fjsmxvwc
 
nzgpgmtjc@pharmon.biz
United States  
9-Apr-20 20:35
95.181.218.53
exfnnopq
 
vfmgudnfe@pharmon.biz
United States  
9-Apr-20 20:07
185.101.70.109
egslvqao
 
dmirkwmkt@pharmon.biz
United States  
9-Apr-20 20:07
185.101.70.109
egslvqao
 
dmirkwmkt@pharmon.biz
United States  
9-Apr-20 19:57
185.101.70.206
tzscizmy
 
ggluiehbs@pharmon.biz
United States  
9-Apr-20 17:45
95.181.218.16
tplvktju
 
awquyppja@pharmon.biz
United States  
9-Apr-20 17:45
95.181.218.16
tplvktju
 
awquyppja@pharmon.biz
United States  
9-Apr-20 17:31
194.104.8.52
gljvdgvu
 
oxfxopnlv@pharmon.biz
Netherlands  
9-Apr-20 17:31
194.104.8.52
gljvdgvu
 
oxfxopnlv@pharmon.biz
Netherlands  
9-Apr-20 17:07
5.62.158.168
cxqnxnwp
 
klfpeovug@pharmon.biz
United States  
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:57
45.10.167.36
mdcjfvva
 
rehgafipt@pharmon.biz
   
9-Apr-20 15:56
5.62.156.130
xgfegfia
 
idxchgdvy@pharmon.biz
United States  
9-Apr-20 15:56
5.62.156.130
xgfegfia
 
idxchgdvy@pharmon.biz
United States  
9-Apr-20 14:19
185.101.70.54
gmqsrfcs
 
cczdhgnkc@pharmon.biz
United States  
9-Apr-20 13:33
5.183.252.77
ytkbbwyu
 
qfudfthzd@pharmon.biz
   
9-Apr-20 13:33
5.183.252.77
ytkbbwyu
 
qfudfthzd@pharmon.biz
   
9-Apr-20 13:25
77.220.195.63
csvayztm
 
glcogkrbu@pharmon.biz
Uzbekistan  
9-Apr-20 12:09
5.62.153.53
nmkpikzs
 
bluprylat@pharmon.biz
United States  
9-Apr-20 12:09
213.108.3.221
mcjguxcc
 
zdkkegarh@pharmon.biz
Russian Federation  
9-Apr-20 09:58
77.220.195.99
cjnovawm
 
hdvpjuswi@pharmon.biz
Uzbekistan  
9-Apr-20 08:44
185.101.70.181
hihisiyp
 
vtukplxwr@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
185.101.70.78
jednpbvb
 
avowikieg@pharmon.biz
United States  
9-Apr-20 08:12
95.181.218.18
hdzffakd
 
sngoynnoj@pharmon.biz
United States  
9-Apr-20 08:12
95.181.218.18
hdzffakd
 
sngoynnoj@pharmon.biz
United States  
9-Apr-20 08:12
95.181.218.18
hdzffakd
 
sngoynnoj@pharmon.biz
United States  
9-Apr-20 07:35
194.104.8.92
uxbikktd
 
vhuqzhxaj@pharmon.biz
Netherlands  
9-Apr-20 07:09
5.62.158.195
drqqxsfm
 
exdfsdifa@pharmon.biz
United States  
9-Apr-20 06:50
77.220.195.80
lewbibvn
 
exbttmagn@pharmon.biz
Uzbekistan  
9-Apr-20 06:50
77.220.195.80
lewbibvn
 
exbttmagn@pharmon.biz
Uzbekistan  
9-Apr-20 06:50
77.220.195.80
lewbibvn
 
exbttmagn@pharmon.biz
Uzbekistan  
9-Apr-20 06:17
5.62.158.58
jnnzeecv
 
fijmbyzio@pharmon.biz
United States  
9-Apr-20 04:34
213.108.3.175
yyvmrqsa
 
idltswhvi@pharmon.biz
Russian Federation  
9-Apr-20 04:34
213.108.3.175
yyvmrqsa
 
idltswhvi@pharmon.biz
Russian Federation  
9-Apr-20 04:34
213.108.3.175
yyvmrqsa
 
idltswhvi@pharmon.biz
Russian Federation  
9-Apr-20 04:34
213.108.3.175
yyvmrqsa
 
idltswhvi@pharmon.biz
Russian Federation  
9-Apr-20 04:34
141.98.84.214
qfcnklxb
 
tppwviywp@pharmon.biz
   
9-Apr-20 04:34
141.98.84.214
qfcnklxb
 
tppwviywp@pharmon.biz
   
9-Apr-20 04:34
141.98.84.214
qfcnklxb
 
tppwviywp@pharmon.biz
   
9-Apr-20 04:27
5.62.153.152
rntewnbq
 
awqbialoy@pharmon.biz
United States  
9-Apr-20 04:20
45.10.167.155
bjmfioxz
 
hpojjulys@pharmon.biz
   
9-Apr-20 04:05
213.108.0.90
znsorspt
 
uljbklisq@pharmon.biz
Russian Federation  
9-Apr-20 00:56
5.62.158.218
mewksgqy
 
whmlfqagd@pharmon.biz
United States  
9-Apr-20 00:44
213.108.0.90
gugfpwai
 
mcvkdbuwj@pharmon.biz
Russian Federation  
9-Apr-20 00:13
45.10.164.146
cglrrzxf
 
dfjizmhvn@pharmon.biz
   
9-Apr-20 00:02
79.110.31.160
rwajrcbe
 
midppinbj@pharmon.biz
Canada  
9-Apr-20 00:02
79.110.31.160
rwajrcbe
 
midppinbj@pharmon.biz
Canada  
8-Apr-20 22:47
5.183.252.137
wntgccjk
 
vxihopguo@pharmon.biz
   
8-Apr-20 22:06
194.104.8.42
mzdooqqt
 
cixpqtcau@pharmon.biz
Netherlands  
8-Apr-20 22:06
194.104.8.42
mzdooqqt
 
cixpqtcau@pharmon.biz
Netherlands  
8-Apr-20 22:06
194.104.8.42
mzdooqqt
 
cixpqtcau@pharmon.biz
Netherlands  
8-Apr-20 22:06
194.104.8.42
mzdooqqt
 
cixpqtcau@pharmon.biz
Netherlands  
8-Apr-20 20:52
213.108.3.30
wyxfvmzx
 
mnjsgkilp@pharmon.biz
Russian Federation  
8-Apr-20 20:32
91.204.14.97
qczzxjxo
 
hfbhquxfe@pharmon.biz
United States  
8-Apr-20 20:32
91.204.14.97
qczzxjxo
 
hfbhquxfe@pharmon.biz
United States  
8-Apr-20 20:03
5.62.158.179
hwxcxzlq
 
xkzlumhmh@pharmon.biz
United States  
8-Apr-20 20:01
5.62.158.218
jdjbeqsp
 
kbtdoklfo@pharmon.biz
United States  
8-Apr-20 19:17
5.62.153.174
nypfjpbn
 
tprmlgabf@pharmon.biz
United States  
8-Apr-20 19:05
185.46.85.109
eqpojtdg
 
ywkffwewv@pharmon.biz
United States  
8-Apr-20 18:41
37.9.45.121
xfmngwkp
 
zbllururm@pharmon.biz
United States  
8-Apr-20 04:57
5.62.153.89
zyunthmh
 
lvymbjdqg@pharmon.biz
United States Evidence
8-Apr-20 01:13
185.46.85.250
ornzwhdn
 
hztxccpgt@pharmon.biz
United States  
7-Apr-20 23:16
213.108.0.159
wdagmrhs
 
ckikqaord@pharmon.biz
Russian Federation  
7-Apr-20 19:53
141.98.84.109
biuclhjf
 
hqbdzxslo@pharmon.biz
  Evidence
7-Apr-20 18:00
37.9.44.124
brixnnqd
 
iiwwqdszm@pharmon.biz
United States  
6-Apr-20 02:51
5.183.252.100
ikfoqgqm
 
iohfrpapt@pharmon.biz
   
5-Apr-20 00:31
37.9.44.13
yuldbqgq
 
wkyyipled@pharmon.biz
United States  
4-Apr-20 15:06
37.9.44.47
hnabebgj
 
nlrhthhhk@pharmon.biz
United States  
4-Apr-20 14:17
5.62.153.133
rllomgsx
 
ppgkjgvpb@pharmon.biz
United States Evidence
2-Apr-20 17:53
185.46.85.31
lzzhtfyu
 
fckdvtanb@pharmon.biz
United States  
2-Apr-20 17:53
185.46.85.31
lzzhtfyu
 
fckdvtanb@pharmon.biz
United States  
2-Apr-20 17:53
185.46.85.31
lzzhtfyu
 
fckdvtanb@pharmon.biz
United States  
1-Apr-20 20:35
5.62.158.102
amdhcpvh
 
kllddmhbs@pharmon.biz
United States  
31-Mar-20 03:17
185.46.85.99
huwlbiis
 
tzyelreqp@pharmon.biz
United States Evidence
30-Mar-20 11:03
5.62.156.81
xvfzvwun
 
thvpzuxus@pharmon.biz
United States  
27-Mar-20 13:06
5.62.158.93
nsaqhtpx
 
mbmzhmdzt@pharmon.biz
United States  
27-Mar-20 05:03
185.101.70.232
ksvepxie
 
onfxkoqfj@pharmon.biz
United States  
27-Mar-20 05:03
185.101.70.232
ksvepxie
 
onfxkoqfj@pharmon.biz
United States  
27-Mar-20 05:03
185.101.70.232
ksvepxie
 
onfxkoqfj@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
37.9.44.201
ifcuescj
 
ferwjlvka@pharmon.biz
United States  
27-Mar-20 03:51
185.46.85.163
qosrzeok
 
qswhjiyuu@pharmon.biz
United States  
Legend
toxic Toxic IP address or "bad" email domain
tor TOR exit node
Highlighted Hot IP or disposable email address

Abuse History for domain pharmon.biz

Close
Close